Cindy Jacobs
2017
In 2017, Cindy Jacobs earned a total compensation of $1.1M as Executive Vice President and Chief Medical Officer at OncoGenex Pharmaceuticals, a 137% increase compared to previous year.
Compensation breakdown
| Option Awards | $574,696 |
|---|---|
| Salary | $413,230 |
| Stock Awards | $158,372 |
| Total | $1,146,298 |
Jacobs received $574.7K in option awards, accounting for 50% of the total pay in 2017.
Jacobs also received $413.2K in salary and $158.4K in stock awards.
Rankings
In 2017, Cindy Jacobs' compensation ranked 8,319th out of 14,666 executives tracked by ExecPay. In other words, Jacobs earned more than 43.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,319 out of 14,666 | 43rd |
Division Manufacturing | 3,155 out of 5,772 | 45th |
Major group Chemicals And Allied Products | 1,042 out of 2,075 | 50th |
Industry group Drugs | 821 out of 1,731 | 53rd |
Industry In Vitro and In Vivo Diagnostic Substances | 29 out of 72 | 60th |
Source: SEC filing on April 19, 2018.
Jacobs' colleagues
We found four more compensation records of executives who worked with Cindy Jacobs at OncoGenex Pharmaceuticals in 2017.
News
OncoGenex Pharmaceuticals CEO John Bencich's 2022 pay slips 7% to $1.5M
April 28, 2023
OncoGenex Pharmaceuticals CEO John Bencich's 2021 pay jumps 82% to $1.6M
April 21, 2022
OncoGenex Pharmaceuticals CEO Richard Stewart's 2020 pay jumps 30% to $1M
March 30, 2021
OncoGenex Pharmaceuticals CEO Richard Stewart's 2019 pay falls 27% to $797K
April 2, 2020
OncoGenex Pharmaceuticals CEO Richard Stewart's 2018 pay jumps 423% to $1.1M
March 28, 2019